Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial

SKIN The Journal of Cutaneous Medicine(2023)

引用 0|浏览22
暂无评分
关键词
severe atopic dermatitis,atopic dermatitis,tralokinumab,pediatric patients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要